Cervical Cancer Screening (CCS)

Assesses women 21–64 years of age who were screened for cervical cancer using either of the following criteria:

  • Women age 21–64 who had cervical cytology performed every 3 years.
  • Women age 30–64 who had cervical cytology/human papillomavirus (HPV) co-testing performed every 5 years.

Why It Matters

Cervical cancer is a disease in which cells in the cervix grow out of control. Cervical cancer used to be one of the most common causes of cancer death for American women; effective screening has reduced the mortality rate by more than 50 percent over the last 30 years.1 Cervical cancer is preventable in most cases because effective screening tests exist. If detected early, cervical cancer is highly treatable.1

Results

CERVICAL CANCER SCREENING RATE*
Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2017 74.3 73.2 59.4 - -
2016 74.3 73.0 58.0 _ _
2015 74.7 71.7 55.8 _ _
2014 76.3 73.8 60.2 _ _
2012 75.5 73.6 64.5 _ _
2011 76.5 74.4 66.7 _ _
2010 77.0 74.5 67.2 _ _
2009 77.3 74.6 65.8 _ _
2008 80.7 74.0 66.0 _ _
2007 81.7 73.5 64.8 _ _
2006 81.0 72.6 65.7 _ _
2005 81.8 74.6 65.2 _ _
2004 80.9 _ 64.7 _ _
2003 81.8 _ 64.0 _ _
2002 80.5 _ 62.2 _ _
2001 80.0 _ 61.1 _ _
2000 78.1 _ _ _ _
1999 71.8 _ _ _ _

*This measure has existed since 1999 and was updated in 2013 to reflect new guidelines from the US Preventive Services Task Force

References

  1. American Cancer Society. 2014. “Cervical Cancer Prevention and Early Detection.” http://www.cancer.org/acs/groups/cid/documents/webcontent/003167-pdf.pdf Last modified December 11.

  • Save

    Save your favorite pages and receive notifications whenever they’re updated.

    You will be prompted to log in to your NCQA account.

  • Email

    Share this page with a friend or colleague by Email.

    We do not share your information with third parties.

  • Print

    Print this page.